Indeed, anti‐CD47 antibody treatments are effective at reducing tumor burden and have been recently found to affect CD8+ T cell function by enhancing dendritic cell (DC) and macrophage activation.11, 13, 14, 15. Here, CD8A is linked to neoplasm.